La Lingua Nostra La Lingua Nostra
Rezultatele cautarii
Vedeti tot
  • Conecteaza-te
    Conecteaza-te
    Inscrie-te
    Căutare
    Night Mode

Căutare

Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni

  • News Feed
  • EXPLORE
  • Pagini
  • Grupuri
  • Events
  • Blogs
  • Offers
  • Jobs
  • Postari
  • Articles
  • Utilizatori
  • Pagini
  • Grupuri
  • Events
  • ROHIT GAURYA a adăugat un fișier Health
    2026-04-08 09:52:39 -
    Ad5-nCoV Vaccine Market Growth & CAGR 12.5% Forecast
    According to a newly published market research report by 24LifeSciences, the global Ad5-nCoV vaccine market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.8 billion by 2032, growing at a compound annual growth rate (CAGR) of 12.5% during the forecast period 2025-2032. Ad5-nCoV, developed by CanSino Biologics, is a recombinant adenovirus type-5 vectored COVID-19 vaccine...
    0 Commentarii 0 Distribuiri 30 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • ROHIT GAURYA a adăugat un fișier Health
    2026-03-18 09:46:28 -
    Meningococcal Polysaccharide Vaccine Market to Reach USD 4.5 Billion by 2030 | CAGR 6.3%
        According to a newly published market research report by 24LifeSciences, global meningococcal polysaccharide vaccine market was valued at USD 2.8 billion in 2023 and is projected to reach USD 4.5 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.3% during the forecast period 2024-2030. Meningococcal polysaccharide vaccines are immunogenic preparations...
    0 Commentarii 0 Distribuiri 235 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • Rohit Katkam a adăugat un fișier Alte
    2026-04-01 10:05:46 -
    Nucleic Vaccine Market Growth Report 2034: Rising at 2.8% CAGR with Expanding Therapeutic Applications
    According to a new report from Intel Market Research, the global Nucleic Vaccine market was valued at USD 49.34 billion in 2024 and is projected to reach USD 59.64 billion by 2034, growing at a CAGR of 2.8% during the forecast period. This growth reflects the transformative impact of mRNA vaccine technology, particularly evident in the rapid response to the COVID-19 pandemic, alongside...
    0 Commentarii 0 Distribuiri 147 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
© 2026 La Lingua Nostra Romaian
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About Termeni Confidențialitate Contacteaza-ne